CRYOFOCUS-B (06922): Anti-Gastroesophageal Reflux System Receives NMPA Approval

Stock News

Dec 16, 2025

CRYOFOCUS-B (06922) announced that on December 15, 2025, its anti-gastroesophageal reflux system, consisting of an implantable anti-reflux device and an esophageal measurement tool, has obtained approval from the National Medical Products Administration (NMPA). With the approval of this system, the company's product portfolio has become more comprehensive and diversified.

The anti-gastroesophageal reflux system is a self-developed surgical device designed for magnetic sphincter augmentation (MSA) procedures to treat gastroesophageal reflux disease (GERD). The MSA procedure aims to enhance the tension of the lower esophageal sphincter (LES) to achieve anti-reflux effects.

The system works by implanting a device in the functional region of the LES outside the esophagus. The magnetic beads within the implanted device generate magnetic attraction, thereby strengthening the LES tension and restoring its anti-reflux function to treat GERD.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1121699847"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1121699847\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1121699847?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-16 18:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121699847","market":"sh","top_or_hot":-1,"title":"CRYOFOCUS-B (06922): Anti-Gastroesophageal Reflux System Receives NMPA Approval","media":"Stock News","content":"<p>CRYOFOCUS-B (06922) announced that on December 15, 2025, its anti-gastroesophageal reflux system, consisting of an implantable anti-reflux device and an esophageal measurement tool, has obtained approval from the National Medical Products Administration (NMPA). With the approval of this system, the company's product portfolio has become more comprehensive and diversified.</p>\n<p>The anti-gastroesophageal reflux system is a self-developed surgical device designed for magnetic sphincter augmentation (MSA) procedures to treat gastroesophageal reflux disease (GERD). The MSA procedure aims to enhance the tension of the lower esophageal sphincter (LES) to achieve anti-reflux effects.</p>\n<p>The system works by implanting a device in the functional region of the LES outside the esophagus. The magnetic beads within the implanted device generate magnetic attraction, thereby strengthening the LES tension and restoring its anti-reflux function to treat GERD.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CRYOFOCUS-B (06922): Anti-Gastroesophageal Reflux System Receives NMPA Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCRYOFOCUS-B (06922): Anti-Gastroesophageal Reflux System Receives NMPA Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-16 18:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CRYOFOCUS-B (06922) announced that on December 15, 2025, its anti-gastroesophageal reflux system, consisting of an implantable anti-reflux device and an esophageal measurement tool, has obtained approval from the National Medical Products Administration (NMPA). With the approval of this system, the company's product portfolio has become more comprehensive and diversified.</p>\n<p>The anti-gastroesophageal reflux system is a self-developed surgical device designed for magnetic sphincter augmentation (MSA) procedures to treat gastroesophageal reflux disease (GERD). The MSA procedure aims to enhance the tension of the lower esophageal sphincter (LES) to achieve anti-reflux effects.</p>\n<p>The system works by implanting a device in the functional region of the LES outside the esophagus. The magnetic beads within the implanted device generate magnetic attraction, thereby strengthening the LES tension and restoring its anti-reflux function to treat GERD.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"医疗保健设备","start_time":0,"source_url":"","article_id":"1121699847","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121699847","pubTimestamp":1765880303,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CRYOFOCUS-B (06922) announced that on December 15, 2025, its anti-gastroesophageal reflux system, consisting of an implantable anti-reflux device and an esophageal measurement tool, has obtained...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1100":"医疗保健设备","06922":"康沣生物-B"},"translate_title":"CRYOFOCUS-B(06922)：抗胃食管反流系统获NMPA批准","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06922":1},"content_text":"CRYOFOCUS-B (06922) announced that on December 15, 2025, its anti-gastroesophageal reflux system, consisting of an implantable anti-reflux device and an esophageal measurement tool, has obtained approval from the National Medical Products Administration (NMPA). With the approval of this system, the company's product portfolio has become more comprehensive and diversified.\nThe anti-gastroesophageal reflux system is a self-developed surgical device designed for magnetic sphincter augmentation (MSA) procedures to treat gastroesophageal reflux disease (GERD). The MSA procedure aims to enhance the tension of the lower esophageal sphincter (LES) to achieve anti-reflux effects.\nThe system works by implanting a device in the functional region of the LES outside the esophagus. The magnetic beads within the implanted device generate magnetic attraction, thereby strengthening the LES tension and restoring its anti-reflux function to treat GERD.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}